|
1
|
Fiedler J and Thum T: MicroRNAs in
myocardial infarction. Arterioscler Thromb Vasc Biol. 33:201–205.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hernández-Reséndiz S, Muñoz-Vega M,
Contreras WE, Crespo-Avilan GE, Rodriguez-Montesinos J,
Arias-Carrión O, Pérez-Méndez O, Boisvert WA, Preissner KT and
Cabrera-Fuentes HA: Responses of Endothelial Cells Towards Ischemic
Conditioning Following Acute Myocardial Infarction. Cond Med.
1:247–258. 2018.PubMed/NCBI
|
|
3
|
Segers VFM, Brutsaert DL and De Keulenaer
GW: Cardiac Remodeling: Endothelial Cells Have More to Say Than
Just NO. Front Physiol. 9:3822018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu C, Wang X, Ha T, Hu Y, Liu L, Zhang X,
Yu H, Miao J, Kao R, Kalbfleisch J, et al: Attenuation of cardiac
dysfunction and remodeling of myocardial infarction by
microRNA-130a are mediated by suppression of PTEN and activation of
PI3K dependent signaling. J Mol Cell Cardiol. 89:(Pt A). 87–97.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang J, Wu S, Barrera J, Matthews K and
Pan D: The Hippo signaling pathway coordinately regulates cell
proliferation and apoptosis by inactivating Yorkie, the Drosophila
Homolog of YAP. Cell. 122:421–434. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim J, Kim YH, Kim J, Park DY, Bae H, Lee
DH, Kim KH, Hong SP, Jang SP, Kubota Y, et al: YAP/TAZ regulates
sprouting angiogenesis and vascular barrier maturation. J Clin
Invest. 127:3441–3461. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim
J, Xie J, Ikenoue T, Yu J, Li L, et al: Inactivation of YAP
oncoprotein by the Hippo pathway is involved in cell contact
inhibition and tissue growth control. Genes Dev. 21:2747–2761.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shao D, Zhai P, Del Re DP, Sciarretta S,
Yabuta N, Nojima H, Lim DS, Pan D and Sadoshima J: A functional
interaction between Hippo-YAP signalling and FoxO1 mediates the
oxidative stress response. Nat Commun. 5:33152014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Q, Li L, Zhao B and Guan KL: The
hippo pathway in heart development, regeneration, and diseases.
Circ Res. 116:1431–1447. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ikeda S and Sadoshima J: Regulation of
Myocardial Cell Growth and Death by the Hippo Pathway. Circ J.
80:1511–1519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh A, Ramesh S, Cibi DM, Yun LS, Li J,
Li L, Manderfield LJ, Olson EN, Epstein JA and Singh MK: Hippo
Signaling Mediators Yap and Taz Are Required in the Epicardium for
Coronary Vasculature Development. Cell Rep. 15:1384–1393. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Del Re DP, Yang Y, Nakano N, Cho J, Zhai
P, Yamamoto T, Zhang N, Yabuta N, Nojima H, Pan D, et al:
Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte
survival and growth to protect against myocardial ischemic injury.
J Biol Chem. 288:3977–3988. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Heallen T, Zhang M, Wang J,
Bonilla-Claudio M, Klysik E, Johnson RL and Martin JF: Hippo
pathway inhibits Wnt signaling to restrain cardiomyocyte
proliferation and heart size. Science. 332:458–461. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sakabe M, Fan J, Odaka Y, Liu N, Hassan A,
Duan X, Stump P, Byerly L, Donaldson M, Hao J, et al: YAP/TAZ-CDC42
signaling regulates vascular tip cell migration. Proc Natl Acad Sci
USA. 114:10918–10923. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jones PD, Kaiser MA, Ghaderi Najafabadi M,
Koplev S, Zhao Y, Douglas G, Kyriakou T, Andrews S, Rajmohan R,
Watkins H, et al: JCAD, a Gene at the 10p11 Coronary Artery Disease
Locus, Regulates Hippo Signaling in Endothelial Cells. Arterioscler
Thromb Vasc Biol. 38:1711–1722. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yates LA, Norbury CJ and Gilbert RJ: The
long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bonauer A, Carmona G, Iwasaki M, Mione M,
Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, et
al: MicroRNA-92a controls angiogenesis and functional recovery of
ischemic tissues in mice. Science. 324:1710–1713. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Rooij E and Olson EN: MicroRNAs:
Powerful new regulators of heart disease and provocative
therapeutic targets. J Clin Invest. 117:2369–2376. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang J, Huang W, Cai W, Wang L, Guo L,
Paul C, Yu XY and Wang Y: Inhibition of microRNA-495 Enhances
Therapeutic Angiogenesis of Human Induced Pluripotent Stem Cells.
Stem Cells. 35:337–350. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tian Y, Liu Y, Wang T, Zhou N, Kong J,
Chen L, Snitow M, Morley M, Li D, Petrenko N, et al: A
microRNA-Hippo pathway that promotes cardiomyocyte proliferation
and cardiac regeneration in mice. Sci Transl Med. 7:279ra382015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang L, Du WW, Yang W, Rutnam ZJ, Peng C,
Li H, O'Malley YQ, Askeland RW, Sugg S, Liu M, et al: MiR-93
enhances angiogenesis and metastasis by targeting LATS2. Cell
Cycle. 11:4352–4365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals, . Guide for the Care and Use of Laboratory Animals. (8th).
National Academies Press (US). (Washington, DC). 2011.
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gao XM, Dart AM, Dewar E, Jennings G and
Du XJ: Serial echocardiographic assessment of left ventricular
dimensions and function after myocardial infarction in mice.
Cardiovasc Res. 45:330–338. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lindsey ML, Kassiri Z, Virag JAI, de
Castro Brás LE and Scherrer-Crosbie M: Guidelines for measuring
cardiac physiology in mice. Am J Physiol Heart Circ Physiol.
314:H733–H752. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu C, Ren D, Wang X, Ha T, Liu L, Lee EJ,
Hu J, Kalbfleisch J, Gao X, Kao R, et al: Toll-like receptor 3
plays a role in myocardial infarction and ischemia/reperfusion
injury. Biochim Biophys Acta. 1842:22–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Empel VP, Bertrand AT, Hofstra L,
Crijns HJ, Doevendans PA and De Windt LJ: Myocyte apoptosis in
heart failure. Cardiovasc Res. 67:21–29. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tse HF, Kwong YL, Chan JK, Lo G, Ho CL and
Lau CP: Angiogenesis in ischaemic myocardium by intramyocardial
autologous bone marrow mononuclear cell implantation. Lancet.
361:47–49. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oka T, Akazawa H, Naito AT and Komuro I:
Angiogenesis and cardiac hypertrophy: Maintenance of cardiac
function and causative roles in heart failure. Circ Res.
114:565–571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Ha T, Gao X, Kelley J, Williams DL,
Browder IW, Kao RL and Li C: NF-kappaB activation is required for
the development of cardiac hypertrophy in vivo. Am J Physiol Heart
Circ Physiol. 287:H1712–H1720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roy S, Khanna S, Hussain SR, Biswas S,
Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ and Sen CK: MicroRNA
expression in response to murine myocardial infarction: miR-21
regulates fibroblast metalloprotease-2 via phosphatase and tensin
homologue. Cardiovasc Res. 82:21–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pinto AR, Ilinykh A, Ivey MJ, Kuwabara JT,
D'Antoni ML, Debuque R, Chandran A, Wang L, Arora K, Rosenthal NA,
et al: Revisiting Cardiac Cellular Composition. Circ Res.
118:400–409. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion--from mechanism to translation. Nat Med. 17:1391–1401.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu J, Jiang M, Deng S, Lu J, Huang H,
Zhang Y, Gong P, Shen X, Ruan H, Jin M, et al: miR-93-5p-Containing
Exosomes Treatment Attenuates Acute Myocardial Infarction-Induced
Myocardial Damage. Mol Ther Nucleic Acids. 11:103–115. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ke ZP, Xu P, Shi Y and Gao AM: MicroRNA-93
inhibits ischemia-reperfusion induced cardiomyocyte apoptosis by
targeting PTEN. Oncotarget. 7:28796–28805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liang L, Zhao L, Zan Y, Zhu Q, Ren J and
Zhao X: MiR-93-5p enhances growth and angiogenesis capacity of
HUVECs by down-regulating EPLIN. Oncotarget. 8:107033–107043. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Heallen T, Morikawa Y, Leach J, Tao G,
Willerson JT, Johnson RL and Martin JF: Hippo signaling impedes
adult heart regeneration. Development. 140:4683–4690. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Matsui Y, Nakano N, Shao D, Gao S, Luo W,
Hong C, Zhai P, Holle E, Yu X, Yabuta N, et al: Lats2 is a negative
regulator of myocyte size in the heart. Circ Res. 103:1309–1318.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
De Boer RA, Pinto YM and Van Veldhuisen
DJ: The imbalance between oxygen demand and supply as a potential
mechanism in the pathophysiology of heart failure: The role of
microvascular growth and abnormalities. Microcirculation.
10:113–126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Choi HJ, Zhang H, Park H, Choi KS, Lee HW,
Agrawal V, Kim YM and Kwon YG: Yes-associated protein regulates
endothelial cell contact-mediated expression of angiopoietin-2. Nat
Commun. 6:69432015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tammela T, Enholm B, Alitalo K and
Paavonen K: The biology of vascular endothelial growth factors.
Cardiovasc Res. 65:550–563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Long J, Wang Y, Wang W, Chang BH and
Danesh FR: Identification of microRNA-93 as a novel regulator of
vascular endothelial growth factor in hyperglycemic conditions. J
Biol Chem. 285:23457–23465. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hazarika S, Farber CR, Dokun AO,
Pitsillides AN, Wang T, Lye RJ and Annex BH: MicroRNA-93 controls
perfusion recovery after hindlimb ischemia by modulating expression
of multiple genes in the cell cycle pathway. Circulation.
127:1818–1828. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Frangogiannis NG and Entman ML: Chemokines
in myocardial ischemia. Trends Cardiovasc Med. 15:163–169. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Frangogiannis NG, Smith CW and Entman ML:
The inflammatory response in myocardial infarction. Cardiovasc Res.
53:31–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Formigli L, Manneschi LI, Nediani C,
Marcelli E, Fratini G, Orlandini SZ and Perna AM: Are macrophages
involved in early myocardial reperfusion injury? Ann Thorac Surg.
71:1596–1602. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kakio T, Matsumori A, Ono K, Ito H,
Matsushima K and Sasayama S: Roles and relationship of macrophages
and monocyte chemotactic and activating factor/monocyte
chemoattractant protein-1 in the ischemic and reperfused rat heart.
Lab Invest. 80:1127–1136. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lv Y, Kim K, Sheng Y, Cho J, Qian Z, Zhao
YY and Hu G, Pan D, Malik AB and Hu G: YAP Controls Endothelial
Activation and Vascular Inflammation Through TRAF6. Circ Res.
123:43–56. 2018. View Article : Google Scholar : PubMed/NCBI
|
